{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:43:13Z","timestamp":1790383393541,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00467-024-06405-6","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T03:54:29Z","timestamp":1716868469000},"page":"2959-2968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-7094","authenticated-orcid":false,"given":"Chiara","family":"De Mutiis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Wenderfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswanath","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Orjuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Sar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Kim","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Yu-hin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornpimol","family":"Rianthavorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"6405_CR1","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1136\/annrheumdis-2017-211663","volume":"76","author":"MG Tektonidou","year":"2017","unstructured":"Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM (2017) Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 76:2009\u20132016","journal-title":"Ann Rheum Dis"},{"key":"6405_CR2","first-page":"2635","volume":"29","author":"S Hagelberg","year":"2002","unstructured":"Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C et al (2002) Longterm follow up of childhood lupus nephritis. J Rheumatol 29:2635\u20132642","journal-title":"J Rheumatol"},{"key":"6405_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ekir.2022.10.014","volume":"8","author":"EY Chan","year":"2022","unstructured":"Chan EY, Yap DY, Wong WT, Wong WH, Wong SW, Lin KY, Hui FY, Yee-Ming J, Lam SS, Wong JK, Lai FF, Ho TW, Tong PC, Lai WM, Chan TM, Ma AL (2022) Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis. Kidney Int Rep 8:141\u2013150. https:\/\/doi.org\/10.1016\/j.ekir.2022.10.014","journal-title":"Kidney Int Rep"},{"key":"6405_CR4","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00467-020-04501-x","volume":"35","author":"A Suhlrie","year":"2020","unstructured":"Suhlrie A, Hennies I, Gellermann J, B\u00fcscher A, Hoyer P, Waldegger S et al (2020) Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study. Pediatr Nephrol 35:1235\u20131246. https:\/\/doi.org\/10.1007\/s00467-020-04501-x","journal-title":"Pediatr Nephrol"},{"key":"6405_CR5","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1136\/annrheumdis-2017-211898","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B et al (2017) European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis 76:1965\u20131973","journal-title":"Ann Rheum Dis"},{"key":"6405_CR6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","volume":"75","author":"K Franklyn","year":"2016","unstructured":"Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF (2016) Asia-Pacific Lupus Collaboration. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis 75:1615\u20131621. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207726","journal-title":"Ann Rheum Dis"},{"key":"6405_CR7","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1093\/rheumatology\/keab746","volume":"61","author":"C De Mutiis","year":"2022","unstructured":"De Mutiis C, Wenderfer SE, Orjuela A, Bagga A, Basu B, Sar T, Aggarwal A, Jain A, Yap HK, Ito S, Ohnishi A, Iwata N, Kasapcopur O, Laurent A, Mastrangelo A, Ogura M, Shima Y, Rianthavorn P, Silva CA, Trindade V, Dormi A, Tullus K (2022) Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis. Rheumatology (Oxford) 61:2563\u20132571. https:\/\/doi.org\/10.1093\/rheumatology\/keab746","journal-title":"Rheumatology (Oxford)"},{"key":"6405_CR8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT et al (2018) Revision of the international society of nephrology\/renal pathology society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789\u2013796","journal-title":"Kidney Int"},{"key":"6405_CR9","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/rheumatology\/keh284","volume":"43","author":"SD Marks","year":"2004","unstructured":"Marks SD, Pilkington C, Woo P, Dillon MJ (2004) The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology 43:1186\u20131189","journal-title":"Rheumatology"},{"key":"6405_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"6405_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637. https:\/\/doi.org\/10.1681\/ASN.2008030287","journal-title":"J Am Soc Nephrol"},{"key":"6405_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","volume":"26","author":"B Qin","year":"2016","unstructured":"Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z, Zhong R (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26:372\u2013376. https:\/\/doi.org\/10.3109\/14397595.2015.1091136","journal-title":"Mod Rheumatol"},{"key":"6405_CR13","first-page":"11026","volume":"8","author":"L Li","year":"2015","unstructured":"Li L, Xia Y, Chen C, Cheng P, Peng C (2015) Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 8:11026\u201311031","journal-title":"Int J Clin Exp Med"},{"key":"6405_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.reuma.2018.07.008","volume":"16","author":"WM Soliman","year":"2020","unstructured":"Soliman WM, Sherif NM, Ghanima IM, El-Badawy MA (2020) Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: relation with disease activity and lupus nephritis. Reumatol Clin (Engl Ed) 16:255\u2013261. https:\/\/doi.org\/10.1016\/j.reuma.2018.07.008","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"6405_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.intimp.2016.04.006","volume":"36","author":"Y Wu","year":"2016","unstructured":"Wu Y, Chen Y, Yang X, Chen L, Yang Y (2016) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol 36:94\u201399. https:\/\/doi.org\/10.1016\/j.intimp.2016.04.006","journal-title":"Int Immunopharmacol"},{"key":"6405_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/0961203310393378","volume":"20","author":"N Firooz","year":"2011","unstructured":"Firooz N, Albert DA, Wallace DJ, Ishimori M, Berel D, Weisman MH (2011) High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 20:588\u2013597. https:\/\/doi.org\/10.1177\/0961203310393378","journal-title":"Lupus"},{"key":"6405_CR17","first-page":"2150","volume":"32","author":"LM Vil\u00e1","year":"2005","unstructured":"Vil\u00e1 LM, Alarc\u00f3n GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2005) LUMINA Study Group. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150\u20132155","journal-title":"J Rheumatol"},{"key":"6405_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","volume":"57","author":"C Gordon","year":"2018","unstructured":"Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D\u2019Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D (2018) British society for rheumatology standards, audit and guidelines working group. The British society for rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford) 57:e1\u2013e45. https:\/\/doi.org\/10.1093\/rheumatology\/kex286","journal-title":"Rheumatology (Oxford)"},{"key":"6405_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0961203319840699","volume":"28","author":"N Abdelrahman","year":"2019","unstructured":"Abdelrahman N, Beresford MW, Leone V (2019) UK Juvenile-onset Systemic Lupus Erythematosus Study Group. Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients. Lupus 28:667\u2013674. https:\/\/doi.org\/10.1177\/0961203319840699","journal-title":"Lupus"},{"key":"6405_CR20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/rheumatology\/39.12.1316","volume":"39","author":"MJ Mirzayan","year":"2000","unstructured":"Mirzayan MJ, Schmidt RE, Witte T (2000) Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology (Oxford) 39:1316\u20131319. https:\/\/doi.org\/10.1093\/rheumatology\/39.12.1316","journal-title":"Rheumatology (Oxford)"},{"key":"6405_CR21","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3899\/jrheum.090019","volume":"36","author":"M Petri","year":"2009","unstructured":"Petri M, Singh S, Tesfasyone H, Malik A (2009) Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study. J Rheumatol 36:2476\u20132480. https:\/\/doi.org\/10.3899\/jrheum.090019","journal-title":"J Rheumatol"},{"key":"6405_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/ard.2008.094508","volume":"68","author":"G Moroni","year":"2009","unstructured":"Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA (2009) Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 68:234\u2013237. https:\/\/doi.org\/10.1136\/ard.2008.094508","journal-title":"Ann Rheum Dis"},{"key":"6405_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.4103\/1319-2442.220863","volume":"28","author":"M Hajji","year":"2017","unstructured":"Hajji M, Harzallah A, Kaaroud H, Barbouch S, Hamida FB, Abdallah TB (2017) Factors associated with relapse of lupus nephritis: a single center study of 249 cases. Saudi J Kidney Dis Transpl 28:1349\u20131355. https:\/\/doi.org\/10.4103\/1319-2442.220863","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"6405_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1136\/ard.2010.135186","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Salmon JE, Boumpas DT (2010) Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 69:1603\u20131611. https:\/\/doi.org\/10.1136\/ard.2010.135186","journal-title":"Ann Rheum Dis"},{"key":"6405_CR25","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1177\/0961203310371154","volume":"19","author":"DJ Birmingham","year":"2010","unstructured":"Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH (2010) The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 19:1272\u20131280. https:\/\/doi.org\/10.1177\/0961203310371154","journal-title":"Lupus"},{"key":"6405_CR26","doi-asserted-by":"publisher","first-page":"R154","DOI":"10.1186\/ar2831","volume":"11","author":"JJ Manson","year":"2009","unstructured":"Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D\u2019Cruz DP, Isenberg DA, Rahman A (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther 11:R154. https:\/\/doi.org\/10.1186\/ar2831","journal-title":"Arthritis Res Ther"},{"key":"6405_CR27","doi-asserted-by":"publisher","first-page":"e000538","DOI":"10.1136\/lupus-2021-000538","volume":"8","author":"RF Van Vollenhoven","year":"2021","unstructured":"Van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, Pons-Estel BA, Rahman A, Ugarte-Gil MF, Voskuyl A, Arnaud L, Bruce IN, Cervera R, Costedoat-Chalumeau N, Gordon C, Houssiau FA, Mosca M, Schneider M, Ward MM, Alarcon G, Aringer M, Askenase A, Bae SC, Bootsma H, Boumpas DT, Brunner H, Clarke AE, Coney C, Czirj\u00e1k L, D\u00f6rner T, Faria R, Fischer R, Fritsch-Stork R, Inanc M, Jacobsen S, Jayne D, Kuhn A, van Leeuw B, Limper M, Mariette X, Navarra S, Nikpour M, Olesinska MH, Pons-Estel G, Romero-Diaz J, Rubio B, Schoenfeld Y, Bonf\u00e1 E, Smolen J, Teng YKO, Tincani A, Tsang-A-Sjoe M, Vasconcelos C, Voss A, Werth VP, Zakharhova E, Aranow C (2021) 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 8:e000538. https:\/\/doi.org\/10.1136\/lupus-2021-000538","journal-title":"Lupus Sci Med"},{"key":"6405_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/art.39026","volume":"67","author":"M Dall'Era","year":"2015","unstructured":"Dall\u2019Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, Rovin BH, Mackay M (2015) Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol 67:1305\u20131313. https:\/\/doi.org\/10.1002\/art.39026","journal-title":"Arthritis Rheumatol"},{"key":"6405_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00467-007-0619-7","volume":"23","author":"M Zappitelli","year":"2008","unstructured":"Zappitelli M, Duffy CM, Bernard C, Gupta IR (2008) Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol 23:83\u201391. https:\/\/doi.org\/10.1007\/s00467-007-0619-7","journal-title":"Pediatr Nephrol"},{"key":"6405_CR30","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/annrheumdis-2020-216965","volume":"79","author":"G Moroni","year":"2020","unstructured":"Moroni G, Gatto M, Tamborini F, Quaglini S, Radice F, Saccon F, Frontini G, Alberici F, Sacchi L, Binda V, Trezzi B, Vaglio A, Messa P, Sinico RA, Doria A (2020) Lack of EULAR\/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis. Ann Rheum Dis 79:1077\u20131083. https:\/\/doi.org\/10.1136\/annrheumdis-2020-216965","journal-title":"Ann Rheum Dis"},{"key":"6405_CR31","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00467-007-0459-5","volume":"22","author":"C Gonz\u00e1lez Celed\u00f3n","year":"2007","unstructured":"Gonz\u00e1lez Celed\u00f3n C, Bitsori M, Tullus K (2007) Progression of chronic renal failure in children with dysplastic kidneys. Pediatr Nephrol 22:1014\u20131020. https:\/\/doi.org\/10.1007\/s00467-007-0459-5","journal-title":"Pediatr Nephrol"},{"key":"6405_CR32","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/s0140-6736(96)09260-4","volume":"349","author":"AM Wingen","year":"1997","unstructured":"Wingen AM, Fabian-Bach C, Schaefer F, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 349:1117\u20131123. https:\/\/doi.org\/10.1016\/s0140-6736(96)09260-4","journal-title":"Lancet"},{"key":"6405_CR33","first-page":"1679","volume-title":"Pediatric Nephrology","author":"E W\u00fchl","year":"2021","unstructured":"W\u00fchl E, Schnaper HW (2021) Progression of chronic kidney disease and nephroprotection in children. In: Emma F, Goldstein S, Bagga A, Bates CM, Shroff R (eds) Pediatric Nephrology. Springer, Berlin, Heidelberg, pp 1679\u20131700"},{"key":"6405_CR34","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00467-020-04788-w","volume":"36","author":"EY Chan","year":"2021","unstructured":"Chan EY, Ma AL, Tullus K (2021) When should we start and stop ACEi\/ARB in paediatric chronic kidney disease? Pediatr Nephrol 36:1751\u20131764. https:\/\/doi.org\/10.1007\/s00467-020-04788-w","journal-title":"Pediatr Nephrol"},{"key":"6405_CR35","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1681\/ASN.2022020207","volume":"33","author":"M Provenzano","year":"2022","unstructured":"Provenzano M, Puchades MJ, Garofalo C, Jongs N, D\u2019Marco L, Andreucci M, De Nicola L, Gorriz JL, Heerspink HJL (2022) ROTATE-3 study group; ROTATE-3 study group members. Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: a randomized crossover clinical trial. J Am Soc Nephrol 33:1569\u20131580. https:\/\/doi.org\/10.1681\/ASN.2022020207","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06405-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06405-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06405-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T15:06:28Z","timestamp":1724771188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06405-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["6405"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06405-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}